Inside Innovation

Seattle-based startup mpathic is expanding to help foundational model developers and LLM-powered application teams reduce dangerous responses and better protect vulnerable users. Founded in 2021

Lundbeck’s intravenous monoclonal antibody significantly reduced the number of monthly migraine days compared to placebo in a phase 2b study after the company had previously

AGC Biologics’ Seattle manufacturing facility has received Good Manufacturing Practices (GMP) certification from Brazil’s health regulatory authority, Agência Nacional de Vigilância Sanitária, enabling biologics and

A new vaccine designed to protect against multiple coronaviruses, including COVID-19, has entered human clinical testing after being developed using technology from the University of

London-based Tenpoint Therapeutics, which has its U.S. headquarters in Seattle, raised $235 million as it prepares to launch its lead eye drop treatment for presbyopia.

The Brotman Baty Institute and the Seattle Hub for Synthetic Biology have selected the first eight postdoctoral researchers for the SeaBridge Fellowship, a new translational

The Gates Foundation and OpenAI are launching a $50 million partnership to deploy artificial intelligence tools in frontline primary health care clinics across Africa, beginning

Pacific Northwest Research Institute (PNRI) researchers have shown that two harmful genetic variants can restore normal function when present together, experimentally validating a decades-old hypothesis

Jubilant HollisterStier plans to expand its Spokane campus with a new $18.5 million building to relocate its allergens processing business unit. The proposed two-story structure

InduPro has entered a collaboration with Eli Lilly to discover new cancer treatments through a deal that could be worth up to $950 million. Under

Variant Bio has launched an AI-powered platform designed to discover new drug candidates using human genetic data. The private biotech company said its Inference platform

Bellevue-based TerraPower announced a deal with Meta to build up to eight small modular nuclear reactors in the U.S. to supply clean energy for the